Department of Psychiatry, Boston Children's Hospital, Boston, Massachusetts.
Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.
JAMA Netw Open. 2019 Jun 5;2(6):e196258. doi: 10.1001/jamanetworkopen.2019.6258.
Annual preventive health visits provide an opportunity to screen youths for unhealthy substance use and intervene before serious harm results.
To assess the feasibility and acceptability and estimate the efficacy of a primary care computer-facilitated screening and practitioner-delivered brief intervention (CSBI) system compared with usual care (UC) for youth substance use and associated risk of riding with an impaired driver.
DESIGN, SETTING, AND PARTICIPANTS: An intent-to-treat pilot randomized clinical trial compared CSBI with UC among 965 youths aged 12 to 18 years at 5 pediatric primary care offices and 54 practitioners. Patients were randomized to CSBI (n = 628) or usual care (n = 243) groups within practitioner with 12 months of follow-up. Data were collected from February 1, 2015, to December 31, 2017. Data analysis was performed January 1, 2018, to March 30, 2019.
Patients self-administered a computer-facilitated substance use screening questionnaire before their annual preventive health visits. Immediately after completing the screening, they received their score and level of risk and viewed 10 pages of scientific information and true-life vignettes illustrating health risks associated with substance use. Trained practitioners received the screening results, patients' risk levels, talking points designed to prompt brief counseling, and recommended follow-up plans.
Feasibility and acceptability were assessed using adolescents' postvisit ratings. Days of alcohol use, cannabis use, and heavy episodic drinking were assessed at baseline and 3-, 6-, 9-, and 12-month follow-ups using Timeline Followback, and riding in the past 3 months with a driver who was impaired by use of alcohol or other drugs was assessed using 2 self-report items. The primary outcome was the intervention effect among at-risk youths who reported using alcohol or other drugs in the past 12 months or riding with an impaired driver in the past 3 months at baseline. The secondary outcome was the prevention effect among those with no prior use or risk.
Among 871 youths screened, 869 completed the baseline assessment; 211 of the 869 reported alcohol or cannabis use in the past 12 months at baseline (mean [SD] age, 16.4 [1.3] years; 114 [54.1%] female; 105 [49.8%] non-Hispanic white). Of the 211 youths, 148 (70.1%) were assigned to the CSBI group and 63 (29.9%) were assigned to the UC group. Among youths in the CSBI group, 105 (70.9%) reported receiving counseling about alcohol, 122 (82.4%) reported receiving counseling about cannabis, and 129 (87.2%) reported receiving counseling about not riding with an impaired driver. Adjusted hazard ratios for time to first postvisit use of alcohol or other drugs for CSBI vs UC were as follows: alcohol use, 0.69 (95% CI, 0.47-1.02); heavy episodic drinking, 0.66 (95% CI, 0.40-1.10); and cannabis use, 0.62 (95% CI, 0.41-0.94). At 12-month follow-ups among 99 youths who reported having ridden in the past 3 months at baseline with an impaired driver (64 in the CSBI group; 35 in the UC group), adjusted relative risk ratio of riding in the past 3 months with an impaired driver for CSBI vs UC groups was 0.58 (95% CI, 0.37-0.91). No intervention effect was observed among youths who reported no prior use of alcohol or other drugs (n = 658) or not having ridden with an impaired driver (n = 769) at baseline.
The CSBI system is a feasible and acceptable option for screening youths in primary care practice for use of alcohol and other drugs and for risk of riding with an impaired driver, and the estimated efficacy in this sample warrants further testing in larger samples.
ClinicalTrials.gov identifier: NCT00227877.
年度预防保健访问提供了一个机会,在严重伤害发生之前筛查青少年的不健康物质使用情况,并进行干预。
评估初级保健计算机辅助筛查和从业者提供的简短干预(CSBI)系统与常规护理(UC)相比,在青少年物质使用和与受影响司机一起乘车的相关风险方面的可行性和可接受性,并估计其疗效。
设计、设置和参与者:一项意向治疗的试点随机临床试验比较了 CSBI 与 5 家儿科初级保健办公室和 54 名从业者内的 UC 对 965 名 12 至 18 岁青少年的使用情况和相关风险。患者在从业者内随机分配到 CSBI(n=628)或 UC 组(n=243),随访 12 个月。数据于 2015 年 2 月 1 日至 2017 年 12 月 31 日收集。数据分析于 2018 年 1 月 1 日至 2019 年 3 月 30 日进行。
患者在年度预防保健访问前自行完成计算机辅助物质使用筛查问卷。在完成筛查后,他们立即查看自己的分数和风险水平,并查看 10 页关于与物质使用相关的健康风险的科学信息和真实生活小插曲。接受过培训的从业者收到了筛查结果、患者的风险水平、旨在提示简短咨询的谈话要点以及推荐的随访计划。
使用青少年就诊后的评分评估可行性和可接受性。使用时间跟踪法在基线和 3、6、9 和 12 个月的随访中评估酒精使用、大麻使用和重度饮酒发作的天数,使用 2 项自我报告项目评估过去 3 个月内与因使用酒精或其他药物而受影响的司机一起乘车的情况。主要结果是在过去 12 个月内报告使用酒精或其他药物或过去 3 个月内报告与受影响司机一起乘车的风险青少年中干预的效果。次要结果是在没有既往使用或风险的青少年中预防的效果。
在 871 名接受筛查的青少年中,869 名完成了基线评估;211 名青少年在基线时报告过去 12 个月内使用过酒精或大麻(平均[SD]年龄 16.4[1.3]岁;114[54.1%]为女性;105[49.8%]为非西班牙裔白人)。在 211 名青少年中,148 名(70.1%)被分配到 CSBI 组,63 名(29.9%)被分配到 UC 组。在 CSBI 组中,105 名(70.9%)报告接受了关于酒精的咨询,122 名(82.4%)报告接受了关于大麻的咨询,129 名(87.2%)报告接受了关于不与受影响的司机一起乘车的咨询。CSBI 与 UC 相比,CSBI 组青少年首次就诊后使用酒精或其他药物的时间调整后的危险比如下:酒精使用,0.69(95%CI,0.47-1.02);重度饮酒发作,0.66(95%CI,0.40-1.10);大麻使用,0.62(95%CI,0.41-0.94)。在基线时有 3 个月内与受影响的司机一起乘车的青少年中,在 99 名接受随访的青少年中,在 12 个月的随访中,在 CSBI 组中报告有 64 名,在 UC 组中报告有 35 名,CSBI 组与 UC 组相比,在过去 3 个月内与受影响的司机一起乘车的调整后的相对风险比为 0.58(95%CI,0.37-0.91)。在基线时没有报告使用过酒精或其他药物(n=658)或没有与受影响的司机一起乘车(n=769)的青少年中,没有观察到干预效果。
CSBI 系统是一种可行且可接受的选择,可用于筛查初级保健实践中青少年的酒精和其他药物使用情况以及与受影响的司机一起乘车的风险,并且在该样本中的估计疗效值得在更大的样本中进一步测试。
ClinicalTrials.gov 标识符:NCT00227877。